BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND JAK2, ENSG00000096968, O60674, JTK10, 3717 AND Prognosis
8 results:

  • 1. Merkel cell polyomavirus-negative Merkel cell carcinoma is associated with JAK-STAT and MEK-ERK pathway activation.
    Iwasaki T; Hayashi K; Matsushita M; Nonaka D; Kohashi K; Kuwamoto S; Umekita Y; Oda Y
    Cancer Sci; 2022 Jan; 113(1):251-260. PubMed ID: 34724284
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Primary cytotoxic T-cell lymphomas harbor recurrent targetable alterations in the JAK-STAT pathway.
    Lee K; Evans MG; Yang L; Ng S; Snowden C; Khodadoust M; Brown RA; Trum NA; Querfeld C; Doan LT; Song J; Zhang H; Gru AA; Wood GS; Wada DA; Shanmugam V; Haun PL; Aster JC; Duncan LM; Guitart J; Weinstock DM; Nardi V; Choi J
    Blood; 2021 Dec; 138(23):2435-2440. PubMed ID: 34432866
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Overexpression of Janus kinase 2 protein in extramammary Paget's disease.
    Otsuka-Maeda S; Mijiddorj MT; Kajihara I; Sakamoto R; Yamada-Kanazawa S; Kanemaru H; Nishimura Y; Sawamura S; Makino K; Aoi J; Makino T; Masuguchi S; Fukushima S; Ihn H
    Jpn J Clin Oncol; 2021 Jul; 51(7):1176-1178. PubMed ID: 33912910
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Deregulation of jak2 signaling underlies primary cutaneous CD8
    Bastidas Torres AN; Cats D; Out-Luiting JJ; Fanoni D; Mei H; Venegoni L; Willemze R; Vermeer MH; Berti E; Tensen CP
    Haematologica; 2022 Mar; 107(3):702-714. PubMed ID: 33792220
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Hypereosinophilic syndromes - An enigmatic group of disorders with an intriguing clinical spectrum and challenging treatment.
    Helbig G; Klion AD
    Blood Rev; 2021 Sep; 49():100809. PubMed ID: 33714638
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A LHFPL3-AS1/miR-580-3p/STAT3 Feedback Loop Promotes the Malignancy in Melanoma via Activation of jak2/STAT3 Signaling.
    Peng Q; Liu L; Pei H; Zhang J; Chen M; Zhai X
    Mol Cancer Res; 2020 Nov; 18(11):1724-1734. PubMed ID: 32753471
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. JAK inhibition synergistically potentiates BCL2, BET, HDAC, and proteasome inhibition in advanced CTCL.
    Yumeen S; Mirza FN; Lewis JM; King ALO; Kim SR; Carlson KR; Umlauf SR; Surovtseva YV; Foss FM; Girardi M
    Blood Adv; 2020 May; 4(10):2213-2226. PubMed ID: 32437546
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Mining database for the expression and gene regulation network of jak2 in skin cutaneous melanoma.
    Zhang W; Zhao H; Chen J; Zhong X; Zeng W; Li Z; Zhou J; He Z; Tang S
    Life Sci; 2020 Jul; 253():117600. PubMed ID: 32234492
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.